The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

In total hip or total knee arthroplasty, hypercoagulability typically begins on the operating table and a hypercoagulable state persists for up to 3 months after surgery. For that reason, it is ...

"We still have a lot of work ahead to define what the most informative prediction/scoring VTE systems are, for both newly diagnosed and relapsed/refractory MM patients, and how we can make them more ...

Venous thromboembolisms are the leading cause of preventable hospital death, underscoring the need for clinical leaders to build a strong prevention program. During a March 24 webinar hosted by Becker ...

(HealthDay News) — Provider-level dashboard and pay-for-performance programs may increase compliance with venous thromboembolism (VTE) prevention measures, according to research published online ...

After publication of potentially practice-changing clinical trials, identified through ASCO's signals approach to updating, an updated systematic review was performed for two guideline questions: ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among hospitalised medical patients. Ongoing efforts to refine risk assessment and optimise prophylactic strategies ...

No increased delirium with hydromorphone after hip surgery Aspirin for 28 days is non-inferior to and as safe as dalteparin for preventing venous thromboembolism. HealthDay News — Twenty-eight days of ...

Protein S deficiency represents a rare but significant hereditary thrombophilia that poses substantial risks during pregnancy ...

Am J Health Syst Pharm. 2012;69(8):658-663. There are inherent limitations to the determination of VTE risk in the population of patients with cirrhosis. In most of the studies evaluated in this ...